Chapter 360-38 PRESCRIPTION DRUG MONITORING PROGRAM

Rule 360-38-.01 Definitions

(1)	'Board' means the Georgia Composite Medical Board.

(2)	'PDMP' means the Georgia Prescription Drug Monitoring Program database.

(3)	'Physician' means an individual licensed to practice medicine pursuant to Article 2 of Chapter 34 of Title 43.

(4)	'Prescriber' means an individual who maintains an active DEA registration to prescribe Schedule Il, Ill, IV or V controlled substances.

(5)	'Controlled medication' means a medication listed in paragraph (l) or (2) of Code Section 16-13-26 or benzodiazepines.

Rule 360-38-.02 PDMP Enrollment

(1)	Prescribers must enroll as a PDMP user by January 1, 2018.

(2)	Prescribers who obtain a DEA registration after January 1, 2018 must enroll with the PDMP within 30-days of obtaining a DEA registration for purposes of prescribing controlled substances in Georgia.

Rule 360-38-.03 Access to PDMP Information

(1)

Access to PDMP information is granted to following personnel:

a.	Prescribers,

b.	Not more than two prescriber's representatives as provided in Code Section 16-13-60, to monitor the PDMP on his/her behalf.

(2)	All information from the PDMP shall be maintained in a secure and confidential manner.

Rule 360-38-.04 Requirements for Checking the PDMP

(1)

On and after July 1, 2018, when a prescriber is prescribing a controlled medication, he or she shall seek and review information from the PDMP the first time he or she issues such prescription to a patient and thereafter at least once every 90-days, unless:

a.	The prescription is for no more than a three-day supply of a controlled medication and no more than 26 pills or:

b.	The patient is in a hospital or health care facility including a nursing and intermediate care home, a personal care home, or a hospice facility where the medication is to be administered and used by a patient on the premises of the facility or:

c.	The patient has had outpatient surgery at a hospital or ambulatory surgical center and the prescription is for no more than a ten-day supply of a controlled medication and no more than 40 pills or;

d.	The patient is terminally ill or under the supervised care of an outpatient hospice program, or;

e.	The patient is receiving treatment for cancer.

(2)

Prescribers or his/her representatives must make a notation in the patient's medical record that the PDMP was consulted and identify the individual who conducted the PDMP search. If the PDMP does not allow access, the prescriber or his/her representatives shall document that access was not permitted and note on the medical record the date, time and name of individual querying the PDMP.

Rule 360-38-.05 Discipline

Failure to comply with the rules and regulations of the Board is grounds for disciplinary action by the Board under O.C.G.A. Section 43-34-8. A prescriber licensed by the Board may be subject to disciplinary action by Board for the failure to maintain the security of PDMP information obtained by him or her or by his or her staff.

Full Name:
Human verification: 4 + 1 =